Skip to contentD
DexCom Inc
D
DXCMDexCom Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.26B$1.26Bderived+13.1% vs Q4 2024 Net Income$267.30M$267.30Mderived+76.2% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DexCom Inc · CIK 1093557 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$792,700,000+20.9% Operating Incomederived$323,000,000+71.0% Operating Cash Flowderived$294,000,000−2.5% Free Cash Flowderived$192,100,000+8.7% Margins · derivedGross margin62.9%+4.0 pt vs Q4 2024
Operating margin25.6%+8.7 pt vs Q4 2024
Net margin21.2%+7.6 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 12, 2026 · 43 d after period end